Apple Self Storage Guelph Achieves Zero Carbon Building-Design Certification
PR Newswire
Today at 11:00pm UTC
HUBG Investor News: If You Have Suffered Losses in Hub Group, Inc. (NASDAQ: HUBG), You Are Encouraged to Contact The Rosen Law Firm About...
GlobeNewswire
Today at 10:33pm UTC
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your...
GlobeNewswire
Today at 10:31pm UTC
Gelatin Trick 2026 Warning: Does the Viral Gelatin Trick Recipe Actually Work? — Pink Gelatin Trick, Ice Gelatin Trick, Bariatric Jello, and...
GlobeNewswire
Today at 9:20pm UTC
DOT Reinforces SAP Gatekeeper Role Amid Rising Industry Risks
PR Newswire
Today at 9:15pm UTC
The Man Who Called the Last Two Crashes Is Warning America Again — And This Time, He's Pointing at AI
GlobeNewswire
Today at 9:00pm UTC
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
PR Newswire
Today at 8:45pm UTC
ThinkCareBelieve: Week 62 of the Trump 2.0 Administration
GlobeNewswire
Today at 8:12pm UTC
No Deposit Bonus Casinos 2026: BitStarz Rolls Out 50 Free Spins No Deposit with Instant Real Money Payouts
GlobeNewswire
Today at 7:41pm UTC
SonarRoom: New iPhone App Reveals the Hidden Acoustic Problems Destroying Your Audio -- 3D Room Mapping Technology Once Reserved for...
PR Newswire
Today at 7:32pm UTC
Steel Power Male Enhancement Claims Evaluated: Complete SteelPower Performance Report for Men
GlobeNewswire
Today at 7:24pm UTC
INVESTOR ALERT: Trip.com Group Limited (TCOM) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
PR Newswire
Today at 7:20pm UTC
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for...
PR Newswire
Today at 7:15pm UTC
NYU Langone Heart Cardiologists Present Latest Clinical Findings and Research at ACC.2026
PR Newswire
Today at 7:02pm UTC
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual...
GlobeNewswire
Today at 7:00pm UTC
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual...
GlobeNewswire
Today at 7:00pm UTC
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
GlobeNewswire
Today at 7:00pm UTC
Gelatide Drops Under Investigation: Full Gelatide-1 Consumer Report Reveals Shocking Hidden Risks & Fake Gelatin Trick Recipe
GlobeNewswire
Today at 6:58pm UTC
North America Water Pump Market Forecast to Reach USD 15 Billion by 2032, Reports MarkNtel Advisors
PR Newswire
Today at 6:36pm UTC
UK Soft Gelatin Capsules Market to Reach USD 408.07 Million by 2032, Growing at a CAGR of 5.8% During 2026-2032 | MarkNtel Advisors
PR Newswire
Today at 6:31pm UTC